These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 26731211)

  • 1. Pharmacologic Vitreolysis in Vascular Diseases of the Retina.
    Soliman MK; Agarwal A; Sarwar S; Hanout M; Sadiq MA; Do DV; Nguyen QD
    Ophthalmic Surg Lasers Imaging Retina; 2016 Jan; 47(1):60-8. PubMed ID: 26731211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic vitreolysis.
    Rhéaume MA; Vavvas D
    Semin Ophthalmol; 2010; 25(5-6):295-302. PubMed ID: 21091015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progression of pharmacologic vitreolysis research].
    Zhou H; Ye J
    Zhonghua Yan Ke Za Zhi; 2014 Mar; 50(3):225-9. PubMed ID: 24841819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocriplasmin for pharmacologic vitreolysis.
    Kuppermann BD
    Retina; 2012 Sep; 32 Suppl 2():S225-8; discussion S228-31. PubMed ID: 22929326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective of pharmacologic vitreolysis.
    Gandorfer A
    Dev Ophthalmol; 2009; 44():1-6. PubMed ID: 19494646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel vitreous modulators for pharmacologic vitreolysis in the treatment of diabetic retinopathy.
    Costa Ede P; Rodrigues EB; Farah ME; Sebag J; Meyer CH
    Curr Pharm Biotechnol; 2011 Mar; 12(3):410-22. PubMed ID: 20939794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological vitreolysis].
    Gandorfer A
    Klin Monbl Augenheilkd; 2011 Mar; 228(3):201-7. PubMed ID: 20845257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic vitreolysis.
    Gandorfer A
    Dev Ophthalmol; 2007; 39():149-156. PubMed ID: 17245084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients.
    Sebag J; Ansari RR; Suh KI
    Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):576-80. PubMed ID: 16941141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic vitreodynamics and molecular flux.
    Goldenberg DT; Trese MT
    Dev Ophthalmol; 2009; 44():31-36. PubMed ID: 19494650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic Vitrectomy and Pharmacologic Vitreodynamics.
    Shah AR; Trese MT
    Dev Ophthalmol; 2016; 55():357-64. PubMed ID: 26501959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreous as a substrate for vitreolysis.
    Bishop PN
    Dev Ophthalmol; 2009; 44():7-19. PubMed ID: 19494647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative imaging of enzymatic vitreolysis-induced fiber remodeling.
    Filas BA; Shah NS; Zhang Q; Shui YB; Lake SP; Beebe DC
    Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8626-37. PubMed ID: 25468895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitreous levels of active ocriplasmin following intravitreal injection: results of an ascending exposure trial.
    Stalmans P; Girach A
    Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6620-7. PubMed ID: 23982845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic vitreolysis with ocriplasmin: rationale for use and therapeutic potential in vitreo-retinal disorders.
    Khoshnevis M; Sebag J
    BioDrugs; 2015 Apr; 29(2):103-12. PubMed ID: 25812991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic vitreolysis--premise and promise of the first decade.
    Sebag J
    Retina; 2009; 29(7):871-4. PubMed ID: 19584647
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacovitrectomy.
    Dolz-Marco R; Gallego-Pinazo R; Díaz-Llopis M; Arévalo JF
    Dev Ophthalmol; 2014; 54():126-34. PubMed ID: 25196761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of proliferative neovascular retinopathies and the role of vitrectomy. A hypothesis.
    Machemer R
    Int Ophthalmol; 1978 Sep; 1(1):1-3. PubMed ID: 95405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the vitreous in retinal vascular disorders.
    Trempe CL; McMeel JW; Jalkh AE
    Bull Soc Belge Ophtalmol; 1987; 223 Pt 2():1-4. PubMed ID: 3502788
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental evaluation of microplasmin - an alternative to vital dyes.
    Gandorfer A
    Dev Ophthalmol; 2008; 42():153-159. PubMed ID: 18535388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.